February 26th, 2025
Yesterday's executive order mandates that healthcare entities disclose the actual prices for items and services—not just estimates—and require that this information be standardized and easily comparable. Federal agencies are directed to update enforcement policies so that data is reported completely, accurately, and meaningfully. These changes are designed to improve the overall quality and usability of price transparency data, which will have important implications for payer-provider negotiations.
Key Mandates of the Order
- Actual Price Disclosure:
Providers and payers must disclose the actual prices of items and services, not estimates. - Standardization of Data:
Pending further guidance from federal agencies, payers and providers will likely face additional requirements for standardization so that pricing information is easily comparable across hospitals and health plans. - Stronger Enforcement:
Also pending further guidance from federal agencies, payers and providers should expect increased enforcement to ensure that disclosed data is complete, accurate, and meaningful.
Impact on Price Transparency Data
The combination of real price disclosure, standardized data, and robust enforcement will enhance both the quality and structure of price transparency information.
- Improvement in Data Quality:
With rigorous enforcement, healthcare entities will be compelled to correct previous data deficiencies. Expect to see fewer gaps, errors, and omissions in the reported machine-readable files (MRFs). Better data quality means both payers and providers can trust the accuracy of competitive intelligence, enabling more confidence in negotiations. - Improvement in Data Structure:
Updated standardization requirements may expand the scope of data elements included in MRFs. Contractual components that were not previously well-documented—such as stoploss terms and value-based arrangements—may now be required. This will allow for a more comprehensive analysis of negotiated arrangements, giving both parties a better understanding of all terms and conditions that affect reimbursement.
What It Means for Payer-Provider Negotiations
Negotiations will become increasingly transparent as both sides gain access to high-quality, accurate data. Where competitor reimbursement terms previously appeared murky, negotiators may find themselves with a clearer picture. The rewards of leveraging MRFs will increase as negotiators are able to access increasingly complete insights, driving better contractual outcomes. This creates an environment where:
- Payers can benchmark their negotiated rates against market peers, ensuring competitive pricing and cost control.
- Providers can justify their pricing demands with clearer data, facilitating more productive discussions with payers.
- Both parties are empowered to make data-driven decisions, ultimately leading to agreements that reflect true market dynamics.
In summary, the executive order accelerates transparent negotiations. It signals the continued evolution of accurate, standardized, and comprehensive pricing data, which forms a solid foundation for reliable competitive intelligence. As healthcare stakeholders adjust to these changes, the negotiation process itself is expected to evolve, becoming more data-driven, efficient, and equitable.
Sources:
